|Agreement labeling||Jisc Thieme 2020-21 Journals Transitional OA Agreement (SMP) – Medical and Chemistry Collections|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2020 – 12/31/2021|
|Consortia / Institution||Jisc|
Approximate range of annual corresponding author publications
|Comments on size/article output||4 subscribers, so overall output covered is lower|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Comments on cost development||Previous Jisc Banded Fee plus uplift range from 1/2 an APC (€1,250) for medical, to 1/3 (€750) of an APC for Chemistry for unlimited output. However, this is offset as previous APC maintained spend is not required.|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY preference, exceptions allowed|
||Original research articles
All types within the defined journals.
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
|Comments on access costs||There is a shift within the two-year period, away from legacy spend|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|Comments on workflows||Messaging to support CC BY selection|
|OVERALL ASSESSMENT AND COMMENTS||The agreement allows unlimited read access to the content and open access publishing in the hybrid journals within the selected collection/s (Chemistry and/or Medicine). This allows for a 100% transition to open access for UK output where institutions participate (chosen collection). The pricing mechanism will need to be adjusted after the initial 2-year phase to transition away further from legacy spend. Work required on workflow for license selection.|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|